This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Medical Practice  • Law and Medicine  • Alert me on articles by topic  Social Bookmarking   What's this?

Bridget M. Kuehn

JAMA. 2005;294:1201.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Lester M. Crawford, DVM, PhD, was confirmed by the Senate as the commissioner of the US Food and Drug Administration (FDA) on July 18.

The Senate confirmed Lester Crawford, DVM, PhD, as the commissioner of the the US Food and Drug Administration. (Photo credit: FDA)

Crawford has been the acting commissioner since March 2004, when Mark B. McClellan, MD, PhD, left the post to become the administrator of the Centers for Medicare & Medicaid Services. He previously served as the agency’s deputy commissioner.

Although President Bush nominated Crawford for commissioner in February, a senate vote to determine his confirmation was delayed after three senators put a hold on the vote. Sen Patty Murray (D, Wash) and Sen Hillary Rodham Clinton (D, NY) did so pending an FDA decision on the over-the-counter emergency contraceptive, Plan B, but released the hold after Department of Health and Human Services Secretary . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?